Valuation: NeuroPace, Inc.

Market Cap 503M 430M 401M 368M 692M 48.08B 706M 4.76B 1.86B 24.1B 1.89B 1.85B 79.78B P/E 2026 *
-29x
P/E 2027 * -54.3x
Enterprise Value 526M 450M 420M 385M 724M 50.3B 738M 4.98B 1.94B 25.21B 1.97B 1.93B 83.46B EV / Sales 2026 *
5.25x
EV / Sales 2027 * 4.23x
Free-Float
83.08%
Yield 2026 *
-
Yield 2027 * -
1 day-4.23%
1 week-3.71%
Current month+8.77%
1 month-12.81%
3 months-11.55%
6 months-3.24%
Current year-9.20%
1 week 13.56
Extreme 13.56
15.28
1 month 12.66
Extreme 12.66
15.88
Current year 12.47
Extreme 12.47
19.6
1 year 8.42
Extreme 8.415
19.6
3 years 4.4
Extreme 4.4
19.6
5 years 1.22
Extreme 1.22
24.65
10 years 1.22
Extreme 1.22
27.38
Manager TitleAgeSince
Chief Executive Officer 58 2023-07-09
Director of Finance/CFO 53 2025-06-19
Chief Tech/Sci/R&D Officer - 2024-09-03
Director TitleAgeSince
Director/Board Member 57 2012-12-31
Chairman 84 1997-11-30
Director/Board Member 46 2021-03-31
Date Insider Type Main position Quantity % Market Cap.
6/19/26 Free

Director

789 0.0023%
5/15/26 Free

Chief Financial Officer

61,620 0.1815%
2/27/26 Tax

Chief Executive Officer

1,126 0.0034%
Change 5-day change 1-year change 3-year change Capi.($)
-4.23%-3.71%+69.94%+212.25% 503M
+2.28%+4.07%+25.94%+17.88% 227B
+2.09%+4.92%+1.75%-14.12% 149B
-5.84%-6.71%-21.88%+30.91% 141B
-5.08%-3.99%-52.41%-1.63% 75.37B
-2.65%-3.46%+13.81%+17.30% 53.19B
-0.43%+2.00%-16.51%-12.52% 51.88B
+0.57%+5.44%+30.13%+31.07% 43.89B
-2.68%-2.75%+35.93%+49.89% 40.86B
-0.75%+2.45%+0.11%+8.32% 33.7B
Average -1.56%+0.03%+8.68%+33.93% 81.54B
Weighted average by Cap. -0.72%+0.46%+2.24%+12.55%

Financials

2026 *2027 *
Net sales 100M 85.81M 80.06M 73.46M 138M 9.59B 141M 950M 370M 4.81B 376M 368M 15.91B 123M 105M 98.02M 89.94M 169M 11.74B 172M 1.16B 453M 5.88B 461M 451M 19.48B
Net income -17.35M -14.85M -13.86M -12.72M -23.9M -1.66B -24.37M -164M -64.09M -832M -65.14M -63.72M -2.75B -9.63M -8.25M -7.7M -7.06M -13.27M -922M -13.53M -91.3M -35.59M -462M -36.17M -35.39M -1.53B
Net Debt 23.21M 19.87M 18.54M 17.01M 31.97M 2.22B 32.6M 220M 85.75M 1.11B 87.16M 85.26M 3.69B 16.02M 13.71M 12.8M 11.74M 22.06M 1.53B 22.5M 152M 59.18M 768M 60.15M 58.84M 2.54B
Logo NeuroPace, Inc.
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.
Employees
220
Date Price Change Volume
26-08-20 US$14.02 -4.23% 191,744
26-08-19 US$14.64 +1.17% 106,610
26-08-18 US$14.47 +1.33% 140,668
26-08-17 US$14.28 -3.32% 197,436
26-08-14 US$14.77 +1.79% 154,960
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
14.64USD
Average target price
20.22USD
Spread / Average Target
+38.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NPCE Stock